Literature DB >> 17898353

The role of dopamine in attentional and memory biases for emotional information.

Ayana A Gibbs1, Kris H Naudts, Edgar P Spencer, Anthony S David.   

Abstract

OBJECTIVE: Cognitive models suggest that biased processing of emotional information may play a role in the genesis and maintenance of psychotic symptoms. The role of dopamine and dopamine antagonists in the processing of such information remains unclear. The authors investigated the effect of a dopamine antagonist on perception of, and memory for, emotional information in healthy volunteers.
METHOD: Thirty-three healthy male volunteers were randomly assigned to a single-blind intervention of either a single dose of the dopamine D(2)/D(3) antagonist amisulpride or placebo. An attentional blink task and an emotional memory task were then administered to assess the affective modulation of attention and memory, respectively.
RESULTS: A significant interaction was observed between stimulus valence and drug on recognition memory accuracy; further contrasts revealed enhanced memory for aversive-arousing compared with neutral stimuli in the placebo but not the amisulpride group. No effect of amisulpride was observed on the perception of emotional stimuli.
CONCLUSIONS: Amisulpride abolished the enhanced memory for emotionally arousing stimuli seen in the placebo group but had no effect on the perception of such stimuli. These results suggests that dopamine plays a significant role in biasing memory toward emotionally salient information and that dopamine antagonists may act by attenuating this bias.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898353     DOI: 10.1176/appi.ajp.2007.06081241

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

Review 1.  New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system.

Authors:  Susan F Volman; Stephan Lammel; Elyssa B Margolis; Yunbok Kim; Jocelyn M Richard; Mitchell F Roitman; Mary Kay Lobo
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

2.  Putative γ-aminobutyric acid neurons in the ventral tegmental area have a similar pattern of plasticity as dopamine neurons during appetitive and aversive learning.

Authors:  Yun-Bok Kim; Marguerite Matthews; Bita Moghaddam
Journal:  Eur J Neurosci       Date:  2010-11       Impact factor: 3.386

3.  Two Routes to Incidental Memory under Arousal: Dopamine and Norepinephrine.

Authors:  John Thorp; David Clewett; Monika Riegel
Journal:  J Neurosci       Date:  2020-02-26       Impact factor: 6.167

4.  Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia.

Authors:  Andrew J Rosenfeld; Jeffrey A Lieberman; L Fredrik Jarskog
Journal:  Schizophr Bull       Date:  2010-03-22       Impact factor: 9.306

5.  Using computational patients to evaluate illness mechanisms in schizophrenia.

Authors:  Ralph E Hoffman; Uli Grasemann; Ralitza Gueorguieva; Donald Quinlan; Douglas Lane; Risto Miikkulainen
Journal:  Biol Psychiatry       Date:  2011-03-11       Impact factor: 13.382

6.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

Review 7.  The dopaminergic basis of human behaviors: A review of molecular imaging studies.

Authors:  Alice Egerton; Mitul A Mehta; Andrew J Montgomery; Julia M Lappin; Oliver D Howes; Suzanne J Reeves; Vincent J Cunningham; Paul M Grasby
Journal:  Neurosci Biobehav Rev       Date:  2009-05-27       Impact factor: 8.989

Review 8.  Emotional memory in schizophrenia.

Authors:  Ellen S Herbener
Journal:  Schizophr Bull       Date:  2008-07-15       Impact factor: 9.306

9.  Thalamic degeneration in MPTP-treated Parkinsonian monkeys: impact upon glutamatergic innervation of striatal cholinergic interneurons.

Authors:  Rosa M Villalba; Jean-Francois Pare; Solah Lee; Sol Lee; Yoland Smith
Journal:  Brain Struct Funct       Date:  2019-11-02       Impact factor: 3.270

10.  Update on the management of symptoms in schizophrenia: focus on amisulpride.

Authors:  Ann M Mortimer
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.